Hepatocellular Carcinoma
Conditions
Keywords
Hepatocellular carcinoma, Registry, Turkey
Brief summary
This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the general profile of HCC patients in Turkey. Socio-demographic characteristics, family history, medical history and treatment pattern of HCC patients will be evaluated.
Interventions
OTHERNo Intervention
All treatment options (inc. surgery, TACE, drugs) will be registered.
Sponsors
Bayer
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* To be diagnosed with hepatocellular carcinoma in last 3 months * To be older than 18 years old * To sign informed consent form (ICF)
Exclusion criteria
* Patients that does not sign or withdraw informed consent form. * According to investigator's opinion; existence of any situation/condition that will significantly complicate patient follow up. * Currently or previously taking part in 3K observational study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Descriptive analysis of HCC risk factors | Baseline | i.e. smoking and alcohol consumption status; family history for hepatitis, HCC, and other malignancies; history of hepatic disease and blood transfusion; concomitant diseases; treatments applied |
| Descriptive analysis of clinical profile of newly diagnosed HCC patients | Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Descriptive analysis of clinical characteristics of HCC patients | Up to approximately 5 years |
| Number of participants with underlying liver disease and family history | Baseline |
| Number of participants with adverse events | Up to approximately 5 years |
| Overall survival time since diagnosis | Up to approximately 5 years |
| Descriptive analysis of tumor properties | Up to approximately 5 years |
| Treatment options as applied by doctors to HCC patients | Up to approximately 5 years |
| Descriptive analysis of demographic characteristics of HCC patients | Baseline |
Countries
Turkey (Türkiye)
Outcome results
None listed